Previous 10 | Next 10 |
PRINCETON, N.J. , Sept. 9, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its P...
Kensington Capital Acquisition (KCAC) +39% as QuantumScape goes public via Kensington Capital merger. More news on: FibroGen, Inc., Fulgent Genetics, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
PRINCETON, N.J. , Sept. 3, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it wi...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
PRINCETON, N.J. , Aug. 27, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its ...
Soligenix (NASDAQ: SNGX ) : Q2 GAAP EPS of -$0.10 beats by $0.04 . Revenue of $0.5M (-64.3% Y/Y) misses by $0.6M . Shares +0.5% PM. Press Release More news on: Soligenix, Inc., Earnings news and commentary, Healthcare stocks news, ,
PRINCETON, N.J. , Aug. 14, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent...
Boxlight (NASDAQ: BOXL ) -27% after pricing equity offering. More news on: Boxlight Corporation, Global Eagle Entertainment Inc., Sypris Solutions, Inc., Stocks on the move, , Read more ...
With two Phase 3 assets approaching clinical trial readouts, a government-funded vaccine program including a potential COVID-19 play, and a valuation of approximately $70 million, Soligenix ( SNGX ) provides a compelling opportunity for investors. Unearthing hidden gems in the biopharma sector...
Eastman Kodak (NYSE: KODK ) +190% . More news on: Eastman Kodak Company, Spectrum Pharmaceuticals, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte...